1. Home
  2. ETNB vs IE Comparison

ETNB vs IE Comparison

Compare ETNB & IE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • IE
  • Stock Information
  • Founded
  • ETNB 2018
  • IE 2020
  • Country
  • ETNB United States
  • IE United States
  • Employees
  • ETNB N/A
  • IE N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • IE Metal Mining
  • Sector
  • ETNB Health Care
  • IE Basic Materials
  • Exchange
  • ETNB Nasdaq
  • IE Nasdaq
  • Market Cap
  • ETNB 1.0B
  • IE 895.0M
  • IPO Year
  • ETNB 2019
  • IE 2022
  • Fundamental
  • Price
  • ETNB $10.05
  • IE $7.55
  • Analyst Decision
  • ETNB Strong Buy
  • IE Strong Buy
  • Analyst Count
  • ETNB 8
  • IE 3
  • Target Price
  • ETNB $26.43
  • IE $12.17
  • AVG Volume (30 Days)
  • ETNB 2.1M
  • IE 722.3K
  • Earning Date
  • ETNB 05-01-2025
  • IE 05-06-2025
  • Dividend Yield
  • ETNB N/A
  • IE N/A
  • EPS Growth
  • ETNB N/A
  • IE N/A
  • EPS
  • ETNB N/A
  • IE N/A
  • Revenue
  • ETNB N/A
  • IE $3,276,000.00
  • Revenue This Year
  • ETNB N/A
  • IE $64.50
  • Revenue Next Year
  • ETNB N/A
  • IE $0.73
  • P/E Ratio
  • ETNB N/A
  • IE N/A
  • Revenue Growth
  • ETNB N/A
  • IE N/A
  • 52 Week Low
  • ETNB $4.16
  • IE $4.50
  • 52 Week High
  • ETNB $11.84
  • IE $12.13
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 68.44
  • IE 69.92
  • Support Level
  • ETNB $8.94
  • IE $7.09
  • Resistance Level
  • ETNB $9.70
  • IE $7.46
  • Average True Range (ATR)
  • ETNB 0.73
  • IE 0.27
  • MACD
  • ETNB 0.14
  • IE 0.06
  • Stochastic Oscillator
  • ETNB 93.78
  • IE 93.53

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About IE Ivanhoe Electric Inc.

Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.

Share on Social Networks: